Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell Cancer
Clinical trial NCT01462214 · COMPLETED
Trial details
- NCT number
- NCT01462214
- Sponsor
- Hans J. van der Vliet, MD, PhD
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2017-01-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.